Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Intravenous Fluid Transfer Drug Devices Market CAGR Outlook And Future Development#_x000D_
The intravenous fluid transfer drug devices market has demonstrated significant expansion in recent years. The market’s value is expected to rise from $7.85 billion in 2025 to $8.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This past growth can be ascribed to several factors, including the widespread reliance on conventional IV sets, an increase in hospital and clinical procedures, the restricted availability of smart infusion devices, heightened awareness regarding the advantages of IV therapy, and the adoption of PVC infusion bags._x000D_
_x000D_
The intravenous fluid transfer drug devices market is projected to demonstrate robust expansion over the next few years. It is forecast to grow to $10.55 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.0%. The anticipated growth during this period stems from various factors, including technological advancements in smart infusion pumps, an increasing demand for pre-filled and multi-chamber infusion bags, wider applications in oncology and neurology, the expansion of home healthcare and ambulatory infusion services, and more stringent regulatory and quality standards. Significant trends expected in the forecast period encompass a rising adoption of smart infusion devices and pumps, an increasing use of pre-filled and multi-chamber infusion bags, growing demand for needleless connectors and safety IV sets, the expansion of IV therapy across chronic and critical care treatments, and an enhanced focus on sterility, accuracy, and flow control._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Intravenous Fluid Transfer Drug Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?#_x000D_
An increasing hospitalization rate is anticipated to fuel the expansion of the intravenous fluid transfer drug device market in the future. This rise in hospitalizations is attributed to an aging population, chronic illnesses, advanced diagnostics, and increased healthcare access, alongside lifestyle-related diseases and medical technology advancements. Fluid transfer systems enable the precise and controlled administration of fluids and medications directly into the bloodstream for hospitalized patients. For instance, in March 2023, according to GOV.UK, a US-based government agency, COVID-19 hospital admissions in England in 2023 saw a slight rise to 10.62 per 100,000, while ICU/HDU admissions stayed low at 0.28 per 100,000. Most regions observed minor increases, with rates remaining largely stable across age groups. Consequently, an upward trend in hospitalization rates will be a significant driver for the intravenous fluid transfer drug device market growth._x000D_
_x000D_
#Intravenous Fluid Transfer Drug Devices Market Segmentation And Category Overview#_x000D_
The intravenous fluid transfer drug devices market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Infusion Bags, Infusion Devices, Other Types_x000D_
2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications_x000D_
3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors_x000D_
_x000D_
Subsegments:_x000D_
1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags _x000D_
2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices _x000D_
3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices_x000D_
_x000D_
#Intravenous Fluid Transfer Drug Devices Market Innovation Trends Shaping Future Development#_x000D_
Leading companies in the intravenous fluid transfer drug device market are actively developing modular and comprehensive infusion systems. These systems integrate features like auto-identification to enhance precision, boost patient safety, and streamline the delivery of fluids and medications. Auto-identification within infusion systems functions by automatically verifying and matching medications to the correct patient through the use of barcode scanning or RFID technology. For example, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, obtained FDA 510(k) clearance for its upgraded BD Alaris Infusion System. This BD Alaris Infusion System features updated hardware for its Point-of-Care Unit (PCU), which includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. Additionally, it introduces an advanced software version with improved cybersecurity and interoperability features, enabling seamless integration with widely adopted electronic medical record (EMR) systems, thereby supporting smart and connected healthcare initiatives._x000D_
_x000D_
#Intravenous Fluid Transfer Drug Devices Market Top Companies Driving Competitive Growth#_x000D_
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG _x000D_
_x000D_
#View The Full Intravenous Fluid Transfer Drug Devices Market Report:#_x000D_
_x000D_
#Intravenous Fluid Transfer Drug Devices Market Global Footprint: Which Region Leads The Market?#_x000D_
North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model